Digital Developing with start-up DNA As head of digital at Sandoz, Andre Heeg is at the forefront of transformation both within his company and the wider industry.
Events Partner Content SMi's 10th Annual RNA Therapeutics Returns this February 201... RNA Therapeutics 2019
Partner Content Partner Content The 10th Annual RNA Therapeutics Returns to London this Feb! RNA Therapeutics
R&D GSK signs $300m R&D deal with 23andMe GlaxoSmithKline signed a $300 million research and development deal with mail gene profiling company 23andMe, gaining access to four million customers DNA information.
Partner Content Partner Content Explore the latest developments in ATMPs at Cell & Gene ... Cell and Gene Therapy 2018
Partner Content Partner Content Attendee List Released for SMi’s 9th Annual RNA Therapeutics RNA Therapeutics
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
